IL-6 can promote the proliferation of prostate cancer and inhibit apoptosis via the JAK/STAT pathway through the extracellular signal-regulated kinase 1 and 2 (ERK1/2)-mitogen activated protein kinase (MAPK) pathway, and the PI3K pathway [53]. Here, MAPK3 is linked to Familial prostate cancer.